Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 11 hours agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
Symptoms of the KP.3 COVID Variant, the New Dominant Strain
Prevention via Yahoo News· 4 days agoThe U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee...
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics - Nature
Nature· 3 days agoOf these participants, ten individuals received pre-emptive remdesivir as previously described7. Volunteers were tested for the presence of anti-SARS-CoV-2 protein antibodies ...
Dr. Anthony Fauci says empathy motivated his medical career but an old phrase from high school kept...
NewsWatch 12 Medford - Klamath Falls· 4 days ago...Health, but he became a veritable household name at the start of the Covid-19 pandemic as part of...
Long COVID Risk Factors Revealed In Data From Nearly 5,000 People
IFLScience· 5 days agoAnalysis of data from 4,700 people recovering from a bout of COVID-19 has revealed more insights...
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 4 days agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 7 days agoA new strain of COVID has prompted recommendations for vaccine companies to update their formulas in anticipation of cases in the fall. The U.S. Food and Drug Administration ...
A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Is Effective in Protecting...
The News & Observer· 2 days agoThe most severe cases that lead to hospitalization and fatalities in respiratory viral infections involve lung damage as an important factor," said Anil R. Diwan, PhD, President and Executive ...
Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News
Zacks via Yahoo Finance· 2 days agoIntra-Cellular Therapies (ITCI) and Zentalis Pharmaceuticals, Inc. (ZNTL) are in the spotlight...
...NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID-...
NewMediaWire via Yahoo Finance· 4 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen,...